Verily announced a $300 million investment round led by Series X Capital with participation from key strategic investors. Alphabet, UCHealth, and the University of Colorado Anschutz joined to support its precision health AI strategy. This funding strengthens Verily’s next phase of healthcare innovation and platform development. Alphabet will remain a significant minority investor but will no longer retain a controlling stake in Verily.
“Today is an important step in our mission to bring the promise of precision health to everyone,” said Stephen Gillett, Chairman and CEO of Verily. “From research to care, our customers need solutions that bring the best of clinical and scientific rigor together with AI to deliver the next generation of healthcare – one that is as precise as it is personal. Series X Capital, Alphabet, UCHealth, the University of Colorado Anschutz and our many investors will be fantastic partners in this transformation of healthcare.”
Strategic Growth and Industry Partnerships
Verily has transitioned from an LLC to a corporation and will now operate as Verily Health Inc. The company plans to accelerate its AI-native precision health platform and expand its roadmap capabilities. It aims to help customers unify healthcare data and deploy actionable insights into research and care workflows. The company continues to expand partnerships, including collaborations with Samsung’s Galaxy Watch and Salesforce integration initiatives.
“Series X Capital was established in collaboration with Google’s X, The Moonshot Factory to scale moonshot technologies into consequential, world-changing companies. We are extremely excited to lead this milestone round for Verily, as they drive commercial momentum as a leader in precision health,” said Gideon Yu, Founder and Managing Partner of Series X Capital.
“At Alphabet, we applaud Verily’s tenacity in using technology to address longstanding challenges in the healthcare industry,” said Ruth Porat, President & Chief Investment Officer, Alphabet and Google. “Bringing in new investors, alongside Alphabet’s ongoing involvement, enables Verily to further scale the business to help improve patient outcomes and lower the cost of healthcare delivery through their AI health platform.”
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
